Misplaced Pages

Pages that link to "BMS-202"

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

← BMS-202

The following pages link to BMS-202

External tools

(link count
transclusion count
sorted list) · See help page for transcluding these entries

Showing 14 items.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

C25H29N3O3 (links | edit)
Nivolumab (links | edit)
Pembrolizumab (links | edit)
Durvalumab (links | edit)
Atezolizumab (links | edit)
Avelumab (links | edit)
Cemiplimab (links | edit)
Dostarlimab (links | edit)
Retifanlimab (links | edit)
Toripalimab (links | edit)
Nivolumab/hyaluronidase (links | edit)
Talk:BMS-202 (transclusion) (links | edit)
Misplaced Pages:WikiProject Academic Journals/Journals cited by Misplaced Pages/DOI/10.2000 (links | edit)
Template:PD-1 and PD-L1 inhibitors (links | edit)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Pages that link to "BMS-202" Add topic